Lei Yu
- Molecular Biology top 10%
- Oncology top 5%
- Biomedical Engineering top 5%
- Biomaterials top 2%
- Immunology top 5%
- Topics
- CAR-T cell therapy research (45 papers)Nanoparticle-Based Drug Delivery (23 papers)RNA Interference and Gene Delivery (13 papers)
- Cited by
- BiomaterialsOncologyImmunology
- Journals
- BloodACS NanoBiomaterials
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lei Yu
97 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.1k
- Oncology 982
- Biomedical Engineering 663
- Biomaterials 495
- Immunology 460
Countries citing papers authored by Lei Yu
This map shows the geographic impact of Lei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yu more than expected).
Fields of papers citing papers by Lei Yu
This network shows the impact of papers produced by Lei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yu. The network helps show where Lei Yu may publish in the future.
Co-authorship network of co-authors of Lei Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Yu. A scholar is included among the top collaborators of Lei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Yu. Lei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 15 | |
| 8 | 12 | |
| 9 | 17 | |
| 10 | 10 | |
| 11 | 4 | |
| 12 | 29 | |
| 13 | 35 | |
| 14 | 49 | |
| 15 | 2 | |
| 16 | 30 | |
| 17 | 3 | |
| 18 | 32 | |
| 19 | 83 | |
| 20 | 20 |
About Lei Yu
Lei Yu is a scholar working on Oncology, Biomaterials and Immunology, having authored 104 papers that have together received 2.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (45 papers), Nanoparticle-Based Drug Delivery (23 papers) and RNA Interference and Gene Delivery (13 papers). The work is most often cited by research in Biomaterials (495 citations), Oncology (982 citations) and Immunology (460 citations). Lei Yu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zhiqiang Yan, Yi‐Ting Wang, Liqing Kang, Lipeng Gao, Sang Van, Nan Xu, Jinge Zhou, Ke Ding, Xiaoyun Lu and Depei Wu. Their work appears in journals such as Blood, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.